|
"guo jhe cyuan"的相关文件
显示项目 1-18 / 18 (共1页) 1 每页显示[10|25|50]项目
臺大學術典藏 |
2022-04-15T07:31:50Z |
Postoperative Imaging and Tumor Marker Surveillance in Resected Pancreatic Cancer
|
Wu, Hsu; Guo, Jhe-Cyuan; Yang, Shih-Hung; YU-WEN TIEN; Kuo, Sung-Hsin |
臺大學術典藏 |
2022-02-21T06:00:15Z |
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
|
Guo, Jhe-Cyuan; Lin, Chen-Yuan; Lin, Chia-Chi; Huang, Ta-Chen; Lien, Ming-Yu; Lu, Li-Chun; HUNG-YANG KUO; CHIH-HUNG HSU |
臺大學術典藏 |
2021-10-21T23:28:03Z |
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
|
Guo, Jhe Cyuan; Lin, Chen Yuan; Chia-Chi Lin; Huang, Ta Chen; Lien, Ming Yu; Lu, Li Chun; HUNG-YANG KUO; Chih-Hung Hsu |
臺大學術典藏 |
2021-09-14T23:18:53Z |
Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy
|
Huang, Ta Chen; Liang, Cher Wei; YU-I LI; Guo, Jhe Cyuan; Chia-Chi Lin; Chen, Ya Jhen; ANN-LII CHENG; CHIH-HUNG HSU |
臺大學術典藏 |
2021-09-09T08:45:43Z |
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
|
GUO, JHE-CYUAN; Lin, Chen-Yuan; Lin, Chia-Chi; Huang, Ta-Chen; Lien, Ming-Yu; Lu, Li-Chun; Kuo, Hung-Yang; Hsu, Chih-Hung |
臺大學術典藏 |
2021-09-09T08:44:01Z |
Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy
|
Huang, Ta-Chen; Liang, Cher-Wei; Li, Yu-I; GUO, JHE-CYUAN; Lin, Chia-Chi; Chen, Ya-Jhen; Cheng, Ann-Lii; Hsu, Chih-Hung |
臺大學術典藏 |
2020-04-09T09:33:46Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Hsu, Chih Hung;Huang, Ta Chen;Shao, Yu Yun;Lien, Ming Yu;Kuo, Hung Yang;Hsieh, Min Shu;Lin, Chen Yuan;Lin, Chia Chi;Guo, Jhe Cyuan; Guo, Jhe Cyuan; Lin, Chia Chi; Lin, Chen Yuan; Hsieh, Min Shu; Kuo, Hung Yang; Lien, Ming Yu; Shao, Yu Yun; Huang, Ta Chen; Hsu, Chih Hung |
臺大學術典藏 |
2019-10-23T13:07:16Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
HUNG-YANG KUO; YU-YUN SHAO; Lin, Chia Chi; Lin, Chen Yuan; Lien, Ming Yu; CHIH-HUNG HSU; Guo, Jhe Cyuan; MIN-SHU HSIEH; Huang, Ta Chen; MIN-SHU HSIEH;CHIH-HUNG HSU;YU-YUN SHAO;HUNG-YANG KUO;Huang, Ta Chen;Guo, Jhe Cyuan;Lien, Ming Yu;Lin, Chen Yuan;Lin, Chia Chi |
臺大學術典藏 |
2019-09-09T00:55:32Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu, Li Chun;YU-YUN SHAO;Shen, Ying Chun;Hsu, Chiun;YI-PING HUNG;CHIH-HUNG HSU;Liu, Tsung Hao;ANN-LII CHENG;Guo, Jhe Cyuan;Yen, Chia Jui;Chang, Chun Jung;I-LUN SHIH;Chao, Yee; Chao, Yee; I-LUN SHIH; Chang, Chun Jung; Yen, Chia Jui; Guo, Jhe Cyuan; ANN-LII CHENG; Liu, Tsung Hao; CHIH-HUNG HSU; YI-PING HUNG; Hsu, Chiun; Shen, Ying Chun; YU-YUN SHAO; Lu, Li Chun |
臺大學術典藏 |
2018-09-10T15:35:44Z |
Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer
|
Yang, S.-H. and Guo, J.-C. and Yeh, K.-H. and Tien, Y.-W. and Cheng, A.-L. and Kuo, S.-H.; Yang, Shih-Hung;Guo, Jhe-Cyuan;Yeh, Kun-Huei;Tien, Yu-Wen;Cheng, Ann-Lii;Kuo, Sung-Hsin; 郭頌鑫;鄭安理;葉坤輝;郭哲銓;田郁文;楊士弘; YU-WEN TIEN; Yang, Shih-Hung; Yang, Shih-Hung; Lin, Chih-Lin; ANN-LII CHENG; Yang, Hung-Chih; Guo, Jhe-Cyuan; Kao, Jia-Horng; Yeh, Kun-Huei; Yeh, Kun-Huei; Tien, Yu-Wen; Tien, Yu-Wen; Cheng, Ann-Lii; Cheng, Ann-Lii; Kuo, Sung-Hsin; Kuo, Sung-Hsin; 高嘉宏; 楊宏志 |
臺大學術典藏 |
2018-09-10T15:33:37Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Yang, S.-H. and Kuo, T.-C. and Wu, H. and Guo, J.-C. and Hsu, C. and Hsu, C.-H. and Tien, Y.-W. and Yeh, K.-H. and Cheng, A.-L. and Kuo, S.-H.; Yang, Shih-Hung;Kuo, Ting-Chun;Wu, Hsu;Guo, Jhe-Cyuan;Hsu, Chiun;Hsu, Chih-Hung;Tien, Yu-Wen;Yeh, Kun-Huei;Cheng, Ann-Lii;Kuo, Sung-Hsin; Yang, Shih-Hung;Kuo, Ting-Chun;Wu, Hsu;Guo, Jhe-Cyuan;Hsu, Chiun;Hsu, Chih-Hung;Tien, Yu-Wen;Yeh, Kun-Huei;Cheng, Ann-Lii;Kuo, Sung-Hsin; 郭頌鑫;鄭安理;徐志宏;許駿;葉坤輝;郭哲銓;田郁文;郭庭均;楊士弘; Yang, Shih-Hung; TING-CHUN KUO; Yang, Shih-Hung; Yang, Shih-Hung; Kuo, Ting-Chun; Kuo, Ting-Chun; YU-WEN TIEN; Kuo, Ting-Chun; ANN-LII CHENG; Wu, Hsu; Guo, Jhe-Cyuan; Guo, Jhe-Cyuan; Hsu, Chiun; Hsu, Chiun; Hsu, Chih-Hung; Hsu, Chih-Hung; Tien, Yu-Wen; Tien, Yu-Wen; Tien, Yu-Wen; Yeh, Kun-Huei; Yeh, Kun-Huei; Yeh, Kun-Huei; Cheng, Ann-Lii; Cheng, Ann-Lii; Kuo, Sung-Hsin; Kuo, Sung-Hsin |
臺大學術典藏 |
2018-09-10T15:18:39Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Hsu, Chih-Hung; Cheng, Ann-Lii; Yeh, Kun-Huei; Wang, Hsiu-Po; Cheng, Jason Chia-Hsien; Lee, Jang-Ming; Huang, Pei-Ming; Chang, Chin-Hao; Hsieh, Min-Shu; PEI-MING HUANG; Lin, Chia-Chi; ANN-LII CHENG; JANG-MING LEE; Guo, Jhe-Cyuan;Huang, Ta-Chen;Lin, Chia-Chi;Hsieh, Min-Shu;Chang, Chin-Hao;Huang, Pei-Ming;Lee, Jang-Ming;Hsu, Feng-Ming;Cheng, Jason Chia-Hsien;Wang, Hsiu-Po;Yeh, Kun-Huei;Cheng, Ann-Lii;Hsu, Chih-Hung; Guo, J.-C. and Huang, T.-C. and Lin, C.-C. and Hsieh, M.-S. and Chang, C.-H. and Huang, P.-M. and Lee, J.-M. and Hsu, F.-M. and Cheng, J.C.-H. and Wang, H.-P. and Yeh, K.-H. and Cheng, A.-L. and Hsu, C.-H.; 林家齊;鄭安理;成佳憲;黃大成;徐志宏;葉坤輝;謝明書;郭哲銓;李章銘;王秀伯;黃培銘;許峰銘;張晉豪; MIN-SHU HSIEH; Guo, Jhe-Cyuan; Huang, Ta-Chen; Hsu, Feng-Ming |
國立臺灣大學 |
2016 |
The recurrence patterns and post-recurrence survivals in patients with locally advanced esophageal squamous cell carcinoma (ESCC) treated with preoperative paclitaxel/cisplatin-based chemoradiotherapy.
|
Kuo, Hung-Yang; Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Hsu, Chih-Hung; 林家齊; 成佳憲; 黃大成; 徐志宏; 葉坤輝; 謝明書; 郭哲銓; 李章銘; 王秀伯 |
國立臺灣大學 |
2016 |
Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer
|
Yang, Shih-Hung; Guo, Jhe-Cyuan; Yeh, Kun-Huei; Tien, Yu-Wen; Cheng, Ann-Lii; Kuo, Sung-Hsin; 郭頌鑫; 鄭安理; 葉坤輝; 郭哲銓; 田郁文; 楊士弘 |
國立臺灣大學 |
2016 |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Yang, Shih-Hung; Kuo, Ting-Chun; Wu, Hsu; Guo, Jhe-Cyuan; Hsu, Chiun; Hsu, Chih-Hung; Tien, Yu-Wen; Yeh, Kun-Huei; Cheng, Ann-Lii; Kuo, Sung-Hsin; 郭頌鑫; 鄭安理; 徐志宏; 許駿; 葉坤輝; 郭哲銓; 田郁文; 郭庭均; 楊士弘 |
國立臺灣大學 |
2015 |
Postchemoradiotherapy (CRT) pathologic stage classified by American Joint Committee on Cancer (AJCC) staging system to predict prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC)
|
Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 林家齊; 鄭安理; 黃大成; 徐志宏; 葉坤輝; 謝明書; 郭哲銓; 王秀伯; 張晉豪 |
國立臺灣大學 |
2015 |
Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
|
Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Huang, Pei-Ming; Lee, Jang-Ming; Hsu, Feng-Ming; Cheng, Jason Chia-Hsien; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 林家齊; 鄭安理; 成佳憲; 黃大成; 徐志宏; 葉坤輝; 謝明書; 郭哲銓; 李章銘; 王秀伯; 黃培銘; 許峰銘; 張晉豪 |
國立臺灣大學 |
2014 |
Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: a retrospective study
|
Guo, Jhe-Cyuan; Yang, Shih-Hung; 郭哲銓; 楊士弘 |
显示项目 1-18 / 18 (共1页) 1 每页显示[10|25|50]项目
|